DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/trr8bf/disease_and) has announced the addition of the "Disease and Therapy Review: Melanoma" report to their offering.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.

The reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

The Melanoma Disease and Therapy Review provides an overview of skin cancer, with incidence, prevalence and mortality numbers, percentages and trends for major countries worldwide, and an overview of treatment by stage and type. Dosing and treatment cost information is provided for various treatment types. General information on the melanoma market, as well as sales of leading drugs and therapies are provided.

Topics Covered:

I. OVERVIEW

General description of the condition

Risk factors

Types of melanoma

Visit link:
Research and Markets: Disease and Therapy Review: Melanoma

Comments are closed.